Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SENSIENT TECHNOLOGIES CORP Director's Dealing 2010

Jul 27, 2010

31054_dirs_2010-07-27_ae224447-d756-42d4-90f1-4fe83b5e3449.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SENSIENT TECHNOLOGIES CORP (SXT)
CIK: 0000310142
Period of Report: 2010-07-26

Reporting Person: HAMMOND JOHN L (Senior VP, Gen Counsel & Secy)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-07-26 Common Stock M 7036 $23.19 Acquired 108806 Direct
2010-07-26 Common Stock M 6964 $23.00 Acquired 115770 Direct
2010-07-26 Common Stock M 3000 $24.15 Acquired 118770 Direct
2010-07-26 Common Stock S 14000 $30.0664 Disposed 104770 Direct
2010-07-26 Common Stock S 3000 $30.0803 Disposed 101770 Direct
2010-07-26 Common Stock S 4500 $30.0665 Disposed 97270 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-07-26 Stock Options (Right to Buy) $23.19 M 7036 Disposed 2012-12-09 Common Stock (7036) Direct
2010-07-26 Stock Options (Right to Buy) $23.00 M 6964 Disposed 2014-12-06 Common Stock (6964) Direct
2010-07-26 Stock Options (Right to Buy) $24.15 M 3000 Disposed 2016-12-07 Common Stock (3000) Direct

Footnotes

F1: Exercise of in-the-money stock option that would otherwise expire on 12/9/2012, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F2: Includes shares of restricted stock held under Issuer's 1998 and 2002 Stock Option Plans.

F3: Exercise of in-the-money stock option that would otherwise expire on 12/6/2014, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F4: Exercise of in-the-money stock option that would otherwise expire on 12/7/2016, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).

F5: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $29.54 to $30.39. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $29.54 to $30.35. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: This amount represents the weighted average sale price for the transactions reported on this line. The actual sale prices ranged from $29.54 to $30.38. The reporting person hereby agrees to provide, upon request by the SEC staff, by the Issuer, or by any security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9: Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.